Incidences of overall and site specific cancers in TNFα inhibitor treated patients with rheumatoid arthritis and other arthritides - a follow-up study from the DANBIO Registry

被引：146

作者：

Dreyer, Lene ^{[1
]}

Mellemkjaer, Lene ^{[2
]}

Andersen, Anne Rodgaard ^{[3
,4
]}

Bennett, Philip ^{[5
]}

Poulsen, Uta Engling ^{[6
]}

Ellingsen, Torkell Juulsgaard ^{[7
]}

Hansen, Torben Hoiland ^{[8
]}

Jensen, Dorte Vendelbo ^{[9
]}

Linde, Louise ^{[3
,4
]}

Lindegaard, Hanne Merete ^{[10
]}

Loft, Anne Gitte Rasmussen ^{[11
]}

Nordin, Henrik ^{[12
]}

Omerovic, Emina ^{[13
]}

Rasmussen, Claus ^{[14
]}

Schlemmer, Annette ^{[15
]}

Tarp, Ulrik ^{[16
]}

Hetland, Merete Lund ^{[3
,4
,17
]}

机构：

[1] Gentofte Univ Hosp, Dept Rheumatol, DK-2900 Hellerup, Denmark

[2] Danish Canc Soc, Res Ctr, Copenhagen, Denmark

[3] Glostrup Univ Hosp, DANBIO Registry, Glostrup, Denmark

[4] Glostrup Univ Hosp, Dept Rheumatol, Glostrup, Denmark

[5] Frederiksberg Univ Hosp, Dept Rheumatol, Frederiksberg, Denmark

[6] Univ So Denmark, Rheumatism Hosp, Dept Rheumatol, Grasten, Denmark

[7] Reg Hosp Silkeborg, Ctr Diagnost, Rheumatol Unit, Silkeborg, Denmark

[8] Holbaek Univ Hosp, Dept Rheumatol, Holbaek, Denmark

[9] Helsingborg Hosp, Dept Rheumatol, Helsingor, Denmark

[10] Odense Univ Hosp, Dept Rheumatol, DK-5000 Odense, Denmark

[11] Hosp Lillebaelt, Vejle Hosp, Dept Rheumatol, Vejle, Denmark

[12] Copenhagen Univ Hosp, Rigshosp, Dept Infect Dis & Rheumatol, Copenhagen, Denmark

[13] Koge Hosp, Dept Rheumatol, Koge, Denmark

[14] Vendsyssel Hosp, Dept Rheumatol, Hjorring, Denmark

[15] Aalborg Univ Hosp, Dept Rheumatol, Aalborg, Denmark

[16] Aarhus Univ Hosp, Dept Rheumatol, DK-8000 Aarhus, Denmark

[17] Dept Rheumatol Denmark, Copenhagen, Denmark

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2013年 / 72卷 / 01期

关键词：

NECROSIS FACTOR THERAPY; BIOLOGICS REGISTER; RISK; MALIGNANCIES; METAANALYSIS; LYMPHOMA; COHORT;

D O I：

10.1136/annrheumdis-2012-201969

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Objectives To investigate the incidence of cancer in arthritis patients treated with or without TNF alpha inhibitors (TNF-I). Methods Arthritis patients from the DANBIO database were followed-up for cancer in the Danish Cancer Registry during 2000-2008. Results Hazard ratio for cancer overall was 1.02 (95% confidence interval (CI) 0.80-1.30) in 3347 TNF-I-treated RA patients compared to non-treated. Excess among TNF-I-treated was found for colon cancer (HR 3.52 (95% CI 1.11-11.15), whereas 6 and 0 ovarian cancer cases were observed in treated and non-treated patients, respectively. Compared to the general population, TNF-I-treated RA patients had increased risk for cancer overall, cancer in lymphatic-haematopoietic tissue and non-melanoma skin cancer, while non-RA patients had no increase in overall cancer risk. Conclusions Our results suggest that TNF-I therapy in routine care is not associated with an overall excess of cancer in arthritis patients, but observed increased risks of colon and ovarian cancer need further investigation.

引用

页码：79 / 82

页数：4

共 20 条

[1] Risks of solid cancers in patients with rheumatoid arthritis and after treatment with tumour necrosis factor antagonists
Askling, J
Fored, CM
Brandt, L
Baecklund, E
Bertilsson, L
Feltelus, N
Cöster, L
Geborek, P
Jacobsson, LT
Lindblad, S
Lysholm, J
Rantapää-Dahlqvist, S
Saxne, T
Klareskog, L
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (10) : 1421 - 1426
[2] Anti-tumour necrosis factor therapy in rheumatoid arthritis and risk of malignant lymphomas: relative risks and time trends in the Swedish Biologics Register
Askling, J.
Baecklund, E.
Granath, F.
Geborek, P.
Fored, M.
Backlin, C.
Bertilsson, L.
Coster, L.
Jacobsson, L. T.
Lindblad, S.
Lysholm, J.
Rantapaa-Dahlqvist, S.
Saxne, T.
van Vollenhoven, R.
Klareskog, L.
Feltelius, N.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2009, 68 (05) : 648 - 653
[3] Cancer risk with tumor necrosis factor alpha (TNF) inhibitors: meta-analysis of randomized controlled trials of adalimumab, etanercept, and infliximab using patient level data
Askling, Johan
Fahrbach, Kyle
Nordstrom, Beth
Ross, Susan
Schmid, Christopher H.
Symmons, Deborah
[J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 (02) : 119 - 130
[4] Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis
Baecklund, E
Iliadou, A
Askling, J
Ekborn, A
Backlin, C
Granath, F
Catrina, AT
Rosenquist, R
Feltelius, N
Sundström, C
Klareskog, L
[J]. ARTHRITIS AND RHEUMATISM, 2006, 54 (03): : 692 - 701
[5] Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials
Bongartz, T
Sutton, AJ
Sweeting, MJ
Buchan, I
Matteson, EL
Montori, V
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19): : 2275 - 2285
[6] High Incidence of Potentially Virus-Induced Malignancies in Systemic Lupus Erythematosus A Long-Term Followup Study in a Danish Cohort
Dreyer, Lene
Faurschou, Mikkel
Mogensen, Mette
Jacobsen, Soren
[J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : 3032 - 3037
[7] Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas
Geborek, P
Bladström, A
Turesson, C
Gulfe, A
Petersson, IF
Saxne, T
Olsson, H
Jacobsson, LTH
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) : 699 - 703
[8] DANBIO-powerful research database and electronic patient record
Hetland, Merete Lund
[J]. RHEUMATOLOGY, 2011, 50 (01) : 69 - 77
[9] What Factors Influence the Health Status of Patients with Rheumatoid Arthritis Measured by the SF-12v2 Health Survey and the Health Assessment Questionnaire?
Linde, Louise
Sorensen, Jan
Ostergaard, Mikkel
Horslev-Petersen, Kim
Rasmussen, Claus
Jensen, Dorte Vendelbo
Hetland, Merete Lund
[J]. JOURNAL OF RHEUMATOLOGY, 2009, 36 (10) : 2183 - 2189
[10] Dietary patterns and colorectal cancer: systematic review and meta-analysis
Magalhaes, Bruno
Peleteiro, Barbara
Lunet, Nuno
[J]. EUROPEAN JOURNAL OF CANCER PREVENTION, 2012, 21 (01) : 15 - 23

← 1 2 →